{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:06:38Z","timestamp":1793736398023,"version":"4.6.1"},"reference-count":65,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Graft-versus-host disease (GVHD), an often-fatal complication of allogeneic hematopoietic cell transplantation, is driven by inflammatory injury that damages target organs of the gastrointestinal (GI) tract, skin, and liver. Effective therapies must not only suppress GVHD reactivity of donor lymphocytes but also permit regeneration of the damaged epithelium, particularly in the GI tract. Systemic corticosteroids are the standard first-line treatment for GVHD because of their powerful immunosuppressive and anti-inflammatory properties but may retard epithelial repair. Ruxolitinib, a selective JAK1\/2 inhibitor, is an approved therapy for steroid-refractory GVHD, although its direct effects on epithelial repair are unknown. Intestinal stem cells (ISCs), which are critical for maintaining gut integrity and barrier function, are key cellular targets of GVHD. We used both ileal and colonic organoid cultures to study the direct effects of methylprednisolone and ruxolitinib under conditions that controlled the strength of the GVH reaction. Ruxolitinib prevented inflammatory apoptosis in both human and murine organoids and preserved ISC function and proliferation, whereas corticosteroids offered no protection and in fact suppressed proliferation. This study highlights the importance of GVHD therapies that facilitate epithelial repair and regeneration, protect target tissues, and suppress alloreactivity of donor T cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017189","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:39:36Z","timestamp":1770327576000},"page":"2431-2440","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Differential effects of GVHD therapies on intestinal epithelium"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-8410","authenticated-orcid":false,"given":"Alberto","family":"Utrero-Rico","sequence":"first","affiliation":[{"name":"1Division of Hematology\/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4340-7439","authenticated-orcid":false,"given":"Urvi","family":"Kapoor","sequence":"additional","affiliation":[{"name":"2Division of Pediatric Hematology\/Oncology\/Stem Cell Transplant, Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenden","family":"Berrios","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7917-0234","authenticated-orcid":false,"given":"George","family":"Morales","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-7828","authenticated-orcid":false,"given":"John E.","family":"Levine","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-538X","authenticated-orcid":false,"given":"Mariano","family":"Prado-Acosta","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8595-3940","authenticated-orcid":false,"given":"James L. M.","family":"Ferrara","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"17","key":"2026041408021021000_bib1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"2026041408021021000_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.bmt.1705265","article-title":"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe","volume":"37","author":"Ljungman","year":"2006","journal-title":"Bone Marrow Transpl"},{"issue":"16","key":"2026041408021021000_bib3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"key":"2026041408021021000_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.immunol.25.022106.141606","article-title":"Immunobiology of allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Welniak","year":"2007","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"2026041408021021000_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc1365","article-title":"Molecules and mechanisms of the graft-versus-leukaemia effect","volume":"4","author":"Bleakley","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2026041408021021000_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"issue":"9674","key":"2026041408021021000_bib7","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"22","key":"2026041408021021000_bib8","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"2026041408021021000_bib9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood-2008-02-138867","article-title":"Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival","volume":"112","author":"Choi","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2026041408021021000_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood.V88.3.1113.1113","article-title":"Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease","volume":"88","author":"Krenger","year":"1996","journal-title":"Blood"},{"issue":"42","key":"2026041408021021000_bib11","doi-asserted-by":"crossref","first-page":"eaay8556","DOI":"10.1126\/sciimmunol.aay8556","article-title":"T cell-derived interferon-\u03b3 programs stem cell death in immune-mediated intestinal damage","volume":"4","author":"Takashima","year":"2019","journal-title":"Sci Immunol"},{"issue":"1","key":"2026041408021021000_bib12","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3026(14)00035-0","article-title":"A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study","volume":"2","author":"Levine","year":"2015","journal-title":"Lancet Haematol"},{"issue":"7583","key":"2026041408021021000_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature16460","article-title":"Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration","volume":"528","author":"Lindemans","year":"2015","journal-title":"Nature"},{"issue":"727","key":"2026041408021021000_bib14","doi-asserted-by":"crossref","first-page":"eadf8366","DOI":"10.1126\/scitranslmed.adf8366","article-title":"Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects","volume":"15","author":"Prado-Acosta","year":"2023","journal-title":"Sci Transl Med"},{"issue":"2","key":"2026041408021021000_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"issue":"7165","key":"2026041408021021000_bib16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"issue":"1","key":"2026041408021021000_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.gastro.2009.05.035","article-title":"OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells","volume":"137","author":"van der Flier","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"2026041408021021000_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/asheducation-2018.1.221","article-title":"GVHD: biology matters","volume":"2018","author":"Ferrara","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"2026041408021021000_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20101559","article-title":"The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells","volume":"208","author":"Takashima","year":"2011","journal-title":"J Exp Med"},{"issue":"18","key":"2026041408021021000_bib20","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/blood.2021011867","article-title":"Graft-versus-host disease: a disorder of tissue regeneration and repair","volume":"138","author":"Chakraverty","year":"2021","journal-title":"Blood"},{"issue":"12","key":"2026041408021021000_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrgastro.2017.126","article-title":"Acute graft-versus-host disease of the gut: considerations for the gastroenterologist","volume":"14","author":"Naymagon","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"2026041408021021000_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/bbmt.2002.v8.pm12171485","article-title":"Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems","volume":"8","author":"MacMillan","year":"2002","journal-title":"Biol Blood Marrow Transpl"},{"key":"2026041408021021000_bib23","doi-asserted-by":"crossref","first-page":"601953","DOI":"10.1155\/2011\/601953","article-title":"Steroid-refractory acute GVHD: predictors and outcomes","volume":"2011","author":"Westin","year":"2011","journal-title":"Adv Hematol"},{"issue":"5","key":"2026041408021021000_bib24","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41375-020-0804-2","article-title":"Treatment and unmet needs in steroid-refractory acute graft-versus-host disease","volume":"34","author":"Malard","year":"2020","journal-title":"Leukemia"},{"issue":"7","key":"2026041408021021000_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbmt.2009.03.012","article-title":"Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement","volume":"15","author":"Martin","year":"2009","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"2026041408021021000_bib26","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","article-title":"First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation","volume":"18","author":"Martin","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"issue":"19","key":"2026041408021021000_bib27","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"2026041408021021000_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft-versus-host disease","volume":"324","author":"Ferrara","year":"1991","journal-title":"N Engl J Med"},{"issue":"5566","key":"2026041408021021000_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"issue":"11","key":"2026041408021021000_bib30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/nm1309","article-title":"A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses","volume":"11","author":"Reddy","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"2026041408021021000_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clim.2006.04.567","article-title":"Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors","volume":"120","author":"Rozkova","year":"2006","journal-title":"Clin Immunol"},{"issue":"1","key":"2026041408021021000_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2006-10-052506","article-title":"Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper","volume":"110","author":"Hamdi","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2026041408021021000_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood.V98.3.743","article-title":"Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB","volume":"98","author":"Ayroldi","year":"2001","journal-title":"Blood"},{"issue":"7","key":"2026041408021021000_bib34","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood-2013-03-484642","article-title":"The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo","volume":"122","author":"Heine","year":"2013","journal-title":"Blood"},{"issue":"19","key":"2026041408021021000_bib35","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1182\/blood-2011-06-363408","article-title":"Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen","volume":"118","author":"Betts","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2026041408021021000_bib36","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/bjh.13373","article-title":"JAK1\/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms","volume":"169","author":"Parampalli Yajnanarayana","year":"2015","journal-title":"Br J Haematol"},{"issue":"7","key":"2026041408021021000_bib37","doi-asserted-by":"crossref","first-page":"e155880","DOI":"10.1172\/JCI155880","article-title":"Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage","volume":"134","author":"Arnhold","year":"2024","journal-title":"J Clin Invest"},{"issue":"26","key":"2026041408021021000_bib38","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1182\/blood.2019004116","article-title":"An intestinal organoid-based platform that recreates susceptibility to T-cell-mediated tissue injury","volume":"135","author":"Matsuzawa-Ishimoto","year":"2020","journal-title":"Blood"},{"issue":"9","key":"2026041408021021000_bib39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/003655201750305495","article-title":"Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro","volume":"36","author":"Jung","year":"2001","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"2026041408021021000_bib40","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41419-021-04151-3","article-title":"TNF-alpha synergises with IFN-gamma to induce caspase-8-JAK1\/2-STAT1-dependent death of intestinal epithelial cells","volume":"12","author":"Woznicki","year":"2021","journal-title":"Cell Death Dis"},{"key":"2026041408021021000_bib41","doi-asserted-by":"crossref","first-page":"1253514","DOI":"10.3389\/fimmu.2023.1253514","article-title":"Novel T cell\/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease","volume":"14","author":"Matthe","year":"2023","journal-title":"Front Immunol"},{"issue":"18","key":"2026041408021021000_bib42","doi-asserted-by":"crossref","first-page":"e121886","DOI":"10.1172\/jci.insight.121886","article-title":"Essential role of IFN-\u03b3 in T cell-associated intestinal inflammation","volume":"3","author":"Eriguchi","year":"2018","journal-title":"JCI Insight"},{"issue":"20","key":"2026041408021021000_bib43","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","article-title":"Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design","volume":"100","author":"Pepe","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2026041408021021000_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2026041408021021000_bib45","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1038\/s41598-023-32438-2","article-title":"Drug cytotoxicity screening using human intestinal organoids propagated with extensive cost-reduction strategies","volume":"13","author":"Takahashi","year":"2023","journal-title":"Sci Rep"},{"issue":"5","key":"2026041408021021000_bib46","doi-asserted-by":"crossref","first-page":"e1228","DOI":"10.1038\/cddis.2014.183","article-title":"Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy","volume":"5","author":"Grabinger","year":"2014","journal-title":"Cell Death Dis"},{"issue":"1","key":"2026041408021021000_bib47","doi-asserted-by":"crossref","first-page":"10412","DOI":"10.1038\/s41598-023-35657-9","article-title":"Suspended hydrogel culture as a method to scale up intestinal organoids","volume":"13","author":"Co","year":"2023","journal-title":"Sci Rep"},{"key":"2026041408021021000_bib48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-0716-3131-7_20","article-title":"Stepwise optimization of real-time RT-PCR analysis","volume":"2653","author":"Maren","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"8","key":"2026041408021021000_bib49","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1182\/bloodadvances.2023012091","article-title":"Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis","volume":"8","author":"Akahoshi","year":"2024","journal-title":"Blood Adv"},{"issue":"13","key":"2026041408021021000_bib50","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2016-09-740431","article-title":"Tissue tolerance: a distinct concept to control acute GVHD severity","volume":"129","author":"Wu","year":"2017","journal-title":"Blood"},{"issue":"19","key":"2026041408021021000_bib51","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/bloodadvances.2017004242","article-title":"IAPs protect host target tissues from graft-versus-host disease in mice","volume":"1","author":"Toubai","year":"2017","journal-title":"Blood Adv"},{"issue":"11","key":"2026041408021021000_bib52","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1172\/JCI99261","article-title":"Survival signal REG3\u03b1 prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease","volume":"128","author":"Zhao","year":"2018","journal-title":"J Clin Invest"},{"issue":"8","key":"2026041408021021000_bib53","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"issue":"1","key":"2026041408021021000_bib54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1060028017728297","article-title":"Optimizing the treatment of steroid-induced hyperglycemia","volume":"52","author":"Wallace","year":"2018","journal-title":"Ann Pharmacother"},{"issue":"15","key":"2026041408021021000_bib55","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","article-title":"Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events","volume":"74","author":"Fardet","year":"2014","journal-title":"Drugs"},{"issue":"1","key":"2026041408021021000_bib56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","article-title":"Infection risk and safety of corticosteroid use","volume":"42","author":"Youssef","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"2026041408021021000_bib57","first-page":"3013","article-title":"High incidence of bloodstream infection detected by surveillance blood cultures in hematology patients on corticosteroid therapy","volume":"20","author":"Joosten","year":"2012","journal-title":"Support Care Cancer"},{"issue":"6","key":"2026041408021021000_bib58","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bbmt.2016.02.020","article-title":"Association of cumulative steroid dose with risk of infection after treatment for severe acute graft-versus-host disease","volume":"22","author":"Matsumura-Kimoto","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"2026041408021021000_bib59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psym.2011.12.007","article-title":"The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited","volume":"53","author":"Dubovsky","year":"2012","journal-title":"Psychosomatics"},{"issue":"18","key":"2026041408021021000_bib60","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood-2017-06-792614","article-title":"Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease","volume":"131","author":"Takahashi","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2026041408021021000_bib61","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.2019000951","article-title":"Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance","volume":"136","author":"Voermans","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2026041408021021000_bib62","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4049\/jimmunol.1700901","article-title":"Mesenchymal stromal cells stimulate the proliferation and IL-22 production of group 3 innate lymphoid cells","volume":"201","author":"van Hoeven","year":"2018","journal-title":"J Immunol"},{"issue":"7","key":"2026041408021021000_bib63","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood-2017-01-762658","article-title":"Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease","volume":"130","author":"Dudakov","year":"2017","journal-title":"Blood"},{"issue":"5","key":"2026041408021021000_bib64","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI91816","article-title":"Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease","volume":"127","author":"Bruce","year":"2017","journal-title":"J Clin Invest"},{"issue":"5","key":"2026041408021021000_bib65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.2022017442","article-title":"Effective treatment of low-risk acute GVHD with itacitinib monotherapy","volume":"141","author":"Etra","year":"2023","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2431\/2512270\/blooda_adv-2025-017189-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2431\/2512270\/blooda_adv-2025-017189-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:02:24Z","timestamp":1776168144000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/7\/2431\/566436\/Differential-effects-of-GVHD-therapies-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017189","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,14]]},"published":{"date-parts":[[2026,4,2]]}}}